The pathological hallmark of AD, amyloid-β plaques, originates from the imprecise cleavage of the amyloid precursor protein (APP) by β-secretase (BACE1) and γ-secretase generating amyloid-β peptide forms [6–9]. This evidence concerns the gene APP and amyloidosis.